Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria

INTRODUCTION: Oncotype DX assay recurrence score (ODX-RS) cut-off values have recently changed after the publication of the TAILOR-X trial results. We aim to explore decisions for adjuvant chemotherapy (ACT) based on physicians' clinical assessment and the evolving ODX-RS. METHODOLOGY: Patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Breast Care (Basel)
Asıl Yazarlar: Zekri, Jamal, Al-Foheidi, Meteb, Alata, Maaz, Zabani, Reem, Rasmy, Ayman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger GmbH 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768137/
https://ncbi.nlm.nih.gov/pubmed/33447239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506389
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller